Showing results (11-20 of 661) with videos related to
Sort By:
Pageof 67
Progress in Cardiovascular Diseases|October 26, 2016
Renin Angiotensin Aldosterone System Inhibitors in Hypertension: Is There Evidence for Benefit Independent of Blood Pressure Reduction?Chirag Bavishi, Sripal Bangalore, Franz H MesserliThe American Journal of Medicine|October 2, 2007
Obesity paradox in patients with hypertension and coronary artery diseaseSeth Uretsky, Franz H Messerli, Sripal Bangalore, et al.JACC. Heart Failure|July 17, 2017
The Transition From Hypertension to Heart Failure: Contemporary UpdateFranz H Messerli, Stefano F Rimoldi, Sripal BangaloreLancet (London, England)|October 16, 2023
β blockers switched to first-line therapy in hypertensionFranz H Messerli, Sripal Bangalore, John M MandrolaJournal of Hypertension|January 25, 2019
Stable coronary artery disease: are there therapeutic benefits of heart rate lowering?Monique S Tanna, Franz H Messerli, Sripal BangaloreJournal of the American Society of Hypertension : JASH|April 23, 2010
Blood pressure, cognitive dysfunction, and dementiaHossein Eftekhari, Seth Uretsky, Franz H MesserliCirculation|June 3, 2011
Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trialsSripal Bangalore, Sunil Kumar, Iryna Lobach, et al.The American Journal of Medicine|August 7, 2007
Fixed-dose combinations improve medication compliance: a meta-analysisSripal Bangalore, Gayathri Kamalakkannan, Sanobar Parkar, et al.The American Journal of Cardiology|June 30, 2015
Meta-Analysis of Comparison of the Newer Oral P2Y12 Inhibitors (Prasugrel or Ticagrelor) to Clopidogrel in Patients With Non-ST-Elevation Acute Coronary SyndromeChirag Bavishi, Sadik Panwar, Franz H Messerli, et al.The American Journal of Cardiology|October 9, 2007
A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitusSripal Bangalore, Sanobar Parkar, Ehud Grossman, et al.Pageof 67